市场调查报告书
商品编码
1466372
切片检查设备市场:按产品、技术、应用和最终用户划分 - 全球预测 2024-2030Biopsy Devices Market by Product (Biopsy Forceps, Localization Wires, Needle-Based Biopsy Instruments), Technique (Image Guided Biopsy, Non-Image Guided Biopsy), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
切片检查设备市场规模预计2023年为94.7亿美元,2024年达到104.6亿美元,预计2030年将达到194.6亿美元,复合年增长率为10.82%。
切片检查装置专门用于诊断程序,提取细胞或组织样本进行测试,以确定疾病的存在或程度。这些设备包括针头、切片检查引导系统、切片检查钳等。切片检查设备在与疾病检测和监测相关的多种医疗应用中发挥重要作用,包括乳房切片、胃肠道切片检查、前列腺切片检查、切片检查和肺部切片检查。全球癌症发生率的增加和对微创手术的偏好是推动市场成长的关键因素。相较之下,高昂的设备成本、与切片检查程序相关的风险以及医疗当局严格的监管障碍正在阻碍市场成长。然而,多家供应商正在集中研究和开发努力来克服这些问题。此外,切片检查设备製造流程的进步、切片检查设备在研究和组织库中的使用增加、医疗保健基础设施的改善以及对新兴国家的投资都有助于市场扩张。
主要市场统计 | |
---|---|
基准年[2023] | 94.7亿美元 |
预测年份 [2024] | 104.6亿美元 |
预测年份 [2030] | 194.6亿美元 |
复合年增长率(%) | 10.82% |
由于产品併发症的风险最小化,人们对针式切片检查设备的偏好增加
切片检查钳是微创手术中使用的复杂手持式仪器,具有两瓣结构。定位线可作为确定切片检查正确部位的指南,尤其是在乳房切片过程中。它用于术前隔离乳房X光摄影或超音波中检测到的不可触及的病变,确保准确性并协助放射科医生获取组织标本。对于深部病变,首选针吸活检装置,常见类型包括细针穿刺活检和粗针穿刺切片。众所周知,这些仪器可以减少手术併发症并有效收集高品质样本,有助于准确诊断。针式切片检查装置包括抽吸针、核心切片检查装置和真空辅助切片检查装置。抽吸针在细针抽吸切片检查中发挥重要作用,细针抽吸活检用于检查肿块和肿块。核心切片检查装置可取出小组织切片进行病理检查,通常用于乳房、肝臟和骨骼切片检查。真空辅助主题是微创切片检查手术的高效工具。该装置采用真空机制,可连续采集组织样本,而无需重新插入针头。手术托盘是一个紧凑、系统化的解决方案,适用于特定手术所需的所有切片检查仪器。优化工作流程,促进资源高效利用,并提高程序无菌性。
技术MRI引导切片检查在实现高诊断准确性的切片检查设备中的重要作用
影像引导切片检查是切片检查设备领域的显着创新,它利用了现代成像技术的精确度。这项先进技术使医生能够从难以进入的区域采集样本,从而实现更精确、侵入性更小的手术。影像引导切片检查包括MRI引导切片检查、立体定位切片检查和超音波引导切片检查。 MRI 导引切片检查已成为诊断难以到达区域或更复杂结构(例如大脑或乳房)异常的首选程序。立体定位切片检查更容易应用于相对表面的异常,例如靠近乳房或皮肤的病灶。此手术的优点是确保患者准确诊断,同时避免侵入性手术带来的不适。超音波引导切片检查是颈部、胸部和腹部切片检查的首选,主要是因为其具有提供即时影像的优势。此外,超音波引导切片检查具有成本效益,并且可以更快地进行切片检查,这使得它们在成本和时间是主要考虑因素的情况下成为首选。相较之下,MRI引导切片检查在晚期病例中处于领先地位,浅表病例需要立体定位切片检查环,而超音波引导切片检查具有即时性要求和成本效益,已被证明在多种情况下是有益的。非影像导引切片检查涉及使用触诊和解剖标誌来确定切片检查部位的技术,无需真实影像引导的帮助。影像切片检查和非影像导引切片检查之间的选择很大程度上取决于病变的位置和性质、患者的健康状况和可用资源。影像引导切片检查在准确性和安全性方面具有广阔的前景,特别是对于不可触及的病变和深部病变。然而,对于表浅肿块,非影像导引切片检查仍然是一种快速且经济高效的选择。
应用 由于乳癌和摄护腺癌的癌症发生率不断增加,对切片检查设备的需求不断增加
随着世界各地乳癌患者数量的增加,对乳房切片检查设备的需求也增加。真空辅助切片检查(VAB) 系统等设备因其微创、可靠的诊断以及快速无痛的过程而越来越受欢迎。柔性乙状结肠镜是结肠切片检查的首选,因为它们可以检测直肠和乙状结肠的异常情况。包括癌症在内的肺部疾病的盛行率不断增加,引发了对切片检查设备的需求,其中常用的是经胸针活检(TTNB)设备。对于摄护腺切片检查,主要使用经直肠超音波(TRUS)引导的摄护腺切片检查切片检查装置。随着癌症发生率的增加,用于乳房和前列腺切片检查的切片检查装置经历了重大的技术进步。同时,用于切片检查和结肠切片检查的设备可用于多种疾病,包括癌症。切片检查设备在医学诊断中至关重要,反映了不断进步并确保患者健康。
最终使用者:增加切片检查设备的使用,以加快医院的復健速度
学术和研究机构寻求创新的解决方案来提高切片检查程序的准确性和效率,特别关注非侵入性程序。这些研究机构正在寻求先进、先进的切片检查设备,以开拓医学研究的新领域。诊断中心和影像诊断中心着重及时、准确的诊断。这些设施需要切片检查装置,以最大限度地减少患者的不适并允许快速采集样本。切片检查设备可实现更短的恢復时间、更少的併发症和更低的成本,是主要关注患者安全、舒适和成本效益的初级医疗保健提供者和医院的理想选择。这些使用者群体的通用目标是提高切片检查程序的准确性和效率。不同的产业需要推动市场发展,带来更细緻的创新并改善全球健康。
区域洞察
在美洲,由于各种癌症患者的增加,切片检查设备的使用正在增加。根据美国癌症协会估计,2023 年将有 1,958,310 例新癌症病例。这与切片检查设备的需求直接相关。最尖端科技和医疗进步以及该地区有利的报销政策正在促进市场成长。此外,人们对癌症早期检测的认识不断提高,再加上强有力的医疗保健行销,这为该地区切片检查设备的更多使用铺平了道路。此外,欧洲、中东和非洲地区对切片检查设备的需求很高,该地区的特点是人口迅速老化和癌症发病率高。技术先进的医疗设备和基础设施的引进也推动了市场的涌入。该地区的国家医疗保健系统促进了及时、准确的癌症诊断,并扩大了切片检查设备的使用范围。世界卫生组织 (WHO) 和欧洲肿瘤研究所进行的宣传宣传活动刺激了该地区对切片检查设备的需求。此外,包括癌症文明病在亚太地区正在迅速增加。人口老化、环境污染和不健康的生活方式正在增加癌症的发生率,并增加对切片检查设备的需求。此外,医疗保健系统的改善、医疗成本的上升以及对早期癌症检测的认识的提高也是推动切片检查设备采用的因素。
FPNV定位矩阵
FPNV 定位矩阵对于评估切片检查设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对切片检查设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.切片检查设备市场的市场规模和预测是多少?
2.在切片检查设备市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?
3.切片检查设备市场的技术趋势和法规结构是什么?
4.切片检查设备市场主要供应商的市场占有率是多少?
5. 进入切片检查设备市场的适当型态和策略手段是什么?
[183 Pages Report] The Biopsy Devices Market size was estimated at USD 9.47 billion in 2023 and expected to reach USD 10.46 billion in 2024, at a CAGR 10.82% to reach USD 19.46 billion by 2030.
The biopsy devices are used explicitly in diagnostic procedures that involve the extraction of sample cells and tissues for examination aimed at identifying the existence and extent of a disease. These devices range from needle biopsy devices, biopsy guidance systems to biopsy forceps. Biopsy devices have a crucial role in several medical applications pertaining to disease detection and monitoring, including breast biopsy, gastrointestinal biopsy, prostate biopsy, liver biopsy, and lung biopsy. An increasing prevalence of cancer worldwide and a growing preference for minimally invasive surgeries are pivotal factors driving the market growth. In contrast, high equipment costs, risks associated with biopsy procedures, and the stringent regulatory hurdles by health authorities hinder the market growth. However, several vendors are focusing on R&D to overcome these issues. Furthermore, advancements in the manufacturing process of biopsy devices, extending the usage of biopsy devices in research and tissue banking, improved healthcare infrastructures, and investments in emerging economies contribute to market expansion.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 9.47 billion |
Estimated Year [2024] | USD 10.46 billion |
Forecast Year [2030] | USD 19.46 billion |
CAGR (%) | 10.82% |
Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
Biopsy forceps are sophisticated, hand-held devices used during minimally invasive procedures, designed with a two-leaf structure; they are adept at extracting tissue samples from targeted areas with sheer precision and minimal patient discomfort. Localization wires act as a guide in identifying the correct area for biopsy, particularly in breast biopsy procedures. They are used preoperatively to seperate non-palpable lesions detected during mammography or ultrasound, ensuring precision and aiding radiologists in obtaining tissue samples. Needle-based biopsy instruments are preferred for deep-seated lesions; common types include fine-needle aspiration and core-needle biopsies. These devices reduce procedural complications and are known for their efficiency in obtaining high-quality samples, helping in precise diagnoses. Needle-based biopsy instruments include aspiration needles, core biopsy devices, and vacuum-assisted biopsy devices. Aspiration needles play a crucial role in fine-needle aspiration biopsy procedures, often used to investigate lumps or masses. Core biopsy devices remove a small tissue section for pathological examination, usually used in breast, liver, or bone biopsies. Vacuum-assisted biopsy devices are remarkably efficient tools for minimally invasive biopsy procedures. Employing a vacuum mechanism, these devices allow for a continuous tissue sample to be acquired without reinserting the needle. Procedure trays are a compact, systematic solution encompassing all necessary biopsy tools for a specific procedure. They optimize the workflow, promote efficient resource use, and enhance the sterility of the procedure.
Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
Image-guided biopsy is a noteworthy innovation in the realm of biopsy devices, harnessing the precision of modern imaging technologies. This advanced technique enables doctors to extract samples from difficult-to-access areas, leading to a more accurate and less invasive procedure. Image-guided biopsy includes MRI-guided biopsy, stereotactic-guided biopsies, and ultrasound-guided biopsy. MRI-guided biopsy has become a preferred technique for diagnosing abnormalities located in difficult-to-reach areas or those of more intricate structures such as the brain and the breast. Stereotactic-guided biopsies are more applicable for relatively superficial abnormalities, including those in the breast and lesions close to the skin. This technique is a boon for patients to avoid the discomfort of invasive procedures while still ensuring a highly accurate diagnosis. Ultrasound-guided biopsy primarily leverages its advantage in real-time image provision, making it the go-to option for neck, chest, and abdomen biopsies. Furthermore, it is a cost-effective and faster way of performing biopsies and is preferred in situations where cost and time are primary considerations. In comparison, MRI-guided biopsy stands at the forefront of advanced cases, stereotactic biopsy rings are necessary for superficial cases, and ultrasound-guided offerings are proven beneficial in real-time requirements and cost-effective scenarios. Non-image guided biopsy includes techniques where palpation or anatomical landmarks are used to determine the biopsy site without the assistance of live-image guidance. The choice between image-guided and non-image-guided biopsies largely depends on the location and nature of the lesion, the patient's health status, and the resources available. Image-guided biopsy methods are leading in the context of precision and safety, particularly for non-palpable and deep-seated lesions. However, non-image-guided procedures remain a fast and cost-effective option for superficial masses.
Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas
The upsurge in breast cancer cases worldwide has subsequently triggered the need for breast biopsy devices. Devices such as vacuum-assisted biopsy (VAB) systems attain favor for their minimally invasive nature, confident diagnosis, and high-speed, painless process. Flexible sigmoidoscopes are preferred for colorectal biopsy due to their ability to detect abnormalities in the rectum and sigmoid colon. The rising incidence of lung conditions, including cancer, triggers the need for lung biopsy devices, where transthoracic needle biopsy (TTNB) devices are commonly used. Prostate biopsy procedures largely use transrectal ultrasound (TRUS) guided prostate biopsy devices, as per need-based preference. Biopsy devices for breast and prostate biopsies are undergoing significant technological advancement owing to rising cancer rates. Simultaneously, devices for lung and colorectal biopsies address a range of illnesses, cancer included. Biopsy devices remain paramount in medical diagnosis, reflecting continuous progress and ensuring patient health.
End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals
Academic and research institutes pursue innovative solutions for improving the accuracy and efficiency of biopsy procedures, with a particular emphasis on non-invasive techniques. These institutions seek sophisticated and advanced biopsy devices that allow them to explore new frontiers of medical research. Diagnostic and imaging centers focus primarily on timely and accurate diagnosis. They require biopsy devices that facilitate rapid sample collection with minimal patient discomfort. Biopsy devices that allow for shorter recovery times, fewer complications, and lower costs are ideally preferred by primary healthcare providers and hospitals as they mainly focus on patient safety, comfort, and cost-effectiveness. The shared objective across these user groups is to enhance biopsy procedure accuracy and efficiency. The varied sector needs to drive market evolution, promising more subtle innovations and improved global health outcomes.
Regional Insights
The Americas region has witnessed a rising trend in the utilization of biopsy devices due to the increase in various cancer cases. According to the American Cancer Society, in 2023, there are estimated to be 1,958,310 new cancer cases. This directly contributes to the need for biopsy devices. State-of-the-art technology and medical advancements, alongside favorable reimbursement policies in this region, contribute to the market growth. Also, growing awareness about early detection of cancer, reinforced by strong healthcare marketing, paves the path for increased use of biopsy devices in the region. Furthermore, the EMEA region, characterized by rapidly aging populations and a high incidence of cancer, has a strong need for biopsy devices. The market inflow is also credited to the adoption of technologically advanced healthcare equipment and infrastructure. National healthcare systems in this region promote timely and accurate cancer diagnosis, enabling increased biopsy device utilization. The awareness campaigns by the World Health Organization (WHO) and the European Institute of Oncology stimulate the need for biopsy devices in the region. Moreover, the APAC region is experiencing a rapid increase in lifestyle-related diseases, including cancers. The aging population, environmental pollution, and unhealthy lifestyle habits are fueling the incidences of cancer, thereby increasing the need for biopsy devices. In addition, improving healthcare systems, increasing healthcare spending, and raising awareness about early cancer detection are other factors fostering the adoption of biopsy devices.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Axlab Limited, B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CONMED Corporation, Cook Group Incorporated, Danaher Corporation, F. Hoffmann-La Roche Ltd., Ferrosan Medical Devices A/S, Fujifilm Holdings Corporation, Guardant Health, Inc., Hologic, Inc., Innovia Medical, INRAD, Inc., Integra LifeSciences Holdings Corporation, IZI Medical Products, LLC by Halma PLC, JEB Technologies Limited, Limaca-Medical, MediTech Devices Pvt Ltd., Medtronic PLC, Merit Medical Systems, Inc., Mermaid Medical, Olympus Corporation, PAJUNK GmbH Medizintechnologie, Remington Medical, Spectra Medical Devices, LLC, Stryker Corporation, Suretech Medical Inc., Trajan Scientific and Medical Pty Ltd., TransMed7, LLC, TSK Laboratory, UVision360, Volkmann MedizinTechnik GmbH, weLLgo Medical Products GmbH, and Zamar Care.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biopsy Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Devices Market?
3. What are the technology trends and regulatory frameworks in the Biopsy Devices Market?
4. What is the market share of the leading vendors in the Biopsy Devices Market?
5. Which modes and strategic moves are suitable for entering the Biopsy Devices Market?